|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/435 |
| (11) | Number of the document | 3319982 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16738403.1 |
| Date of filing the European patent application | 2016-07-08 | |
| (97) | Date of publication of the European application | 2018-05-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/066299 |
| Date | 2016-07-08 |
| (87) | Number | WO 2017/009236 |
| Date | 2017-01-19 |
| (30) | Number | Date | Country code |
| 15306141 | 2015-07-10 | EP |
| (72) |
BOSSART, Martin, DE
EVERS, Andreas, DE
HAACK, Torsten, DE
LORENZ, Katrin, DE
KADEREIT, Dieter, DE
WAGNER, Michael, DE
HENKEL, Bernd, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |
| NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |